Erasca (ERAS) Change in Account Payables (2020 - 2026)
Erasca (ERAS) posted Change in Account Payables of $1.2 million for Q1 2026, up 157.71% on a QoQ basis from -$2.0 million in Q4 2025, and down 34.11% year-over-year from $1.8 million in Q1 2025.
Erasca (ERAS) Change in Account Payables (2020 - 2026) Analysis & Trends
Erasca's Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Change in Account Payables fell 34.11% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$99000.0 (up 73.32% YoY) and the FY2025 annual result came in at $513000.0, up 133.49% from the prior year.
- Change in Account Payables was $1.2 million for Q1 2026 at Erasca, up from -$2.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.9 million in Q1 2022 and bottomed at -$2.0 million in Q4 2025.
- A 5-year average of -$2764.7 and a median of $446000.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 992.4% in 2022, while the deepest fall reached 565.19% in 2022.
- Erasca's Change in Account Payables stood at -$864000.0 in 2022, then tumbled by 92.48% to -$1.7 million in 2023, then dropped by 16.48% to -$1.9 million in 2024, then declined by 5.73% to -$2.0 million in 2025, then soared by 157.71% to $1.2 million in 2026.
- Business Quant data shows ERAS's Change in Account Payables at $1.2 million in Q1 2026, -$2.0 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -599,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 482,000.00 |
| Sep 30, 2024 | 482,000.00 |
| Jun 30, 2024 | -710,000.00 |
| Jun 30, 2024 | -710,000.00 |
| Mar 31, 2024 | 633,000.00 |
| Mar 31, 2024 | 633,000.00 |
| Dec 31, 2023 | -1.66 Mn |
| Dec 31, 2023 | -1.66 Mn |